Verified stock metrics
TScan Therapeutics Key Stock Metrics
Direct answer
TScan Therapeutics has 8 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked October 16, 2026.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $15.90M
- Price-to-book ratio
- 0.23x
- Return on equity
- -95.8%
- Dividend yield
- 0%
- 52-week price range
- $0.20 to $2.57
- Revenue growth
- -65.8%
- Profit margin
- 0%
- Debt-to-equity ratio
- 131.69%
Explore related company data
View TScan Therapeutics's market capitalizationView TScan Therapeutics's price-to-book ratioView TScan Therapeutics's return on equityView TScan Therapeutics's dividend yieldView TScan Therapeutics's 52-week price rangeView TScan Therapeutics's revenue growthView TScan Therapeutics's profit marginView TScan Therapeutics's debt-to-equity ratioReturn to TScan Therapeutics profile